Related Experiment Video
Updated: May 30, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Mechanistic insights into nicotine withdrawal
Michael Paolini1, Mariella De Biasi
1Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.
Biochemical Pharmacology
|July 26, 2011
Summary
Quitting smoking helps prevent premature death and reduces healthcare costs. Understanding nicotine withdrawal mechanisms, including brain changes and the habenula
Area of Science:
- Neuroscience
- Addiction Medicine
- Pharmacology
Background:
- Smoking causes over 400,000 deaths annually in the US, leading to significant healthcare costs and lost productivity.
- Nicotine withdrawal symptoms are a major barrier to successful smoking cessation, despite widespread desire to quit.
- Understanding the neurobiological underpinnings of nicotine addiction and withdrawal is crucial for developing effective cessation strategies.
Purpose of the Study:
- To review the neuroadaptations resulting from chronic nicotine exposure.
- To elucidate the mechanisms driving nicotine withdrawal syndrome.
- To explore the role of the habenula and nicotinic receptor subtypes in nicotine dependence and cessation.
Main Methods:
- Review of existing scientific literature on nicotine neurobiology and withdrawal.
- Analysis of the endogenous reward system's interaction with nicotine.
- Examination of the habenula's role in aversion and withdrawal.
- Summary of nicotinic acetylcholine receptor (nAChR) subtype involvement.
Main Results:
- Chronic nicotine exposure induces neuroadaptations that precipitate withdrawal symptoms upon cessation.
- Nicotine hijacks the brain's reward pathways, contributing to dependence.
- The habenula is implicated in the aversive aspects of nicotine use and withdrawal.
- Specific nicotinic receptor subtypes play distinct roles in mediating withdrawal phenomena.
Conclusions:
- Neuroadaptations to nicotine create a cycle of dependence and withdrawal, hindering cessation.
- Targeting the habenula and specific nicotinic receptor subtypes may offer novel therapeutic avenues for smoking cessation.
- Further research into these mechanisms can inform the development of more effective treatments to aid smokers in quitting.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...